Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib-MenC vs NeisVac-C with Infanrix in Infants
NCT00327184Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Primary completion
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Hib-MenC-TT in meningococcal serogroup C disease, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Apr 2006; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
meningococcal serogroup C diseaseHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00327184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327184.